182. Brigham Buhler: The Peptide Safety Data Reveals 75,000+ Patients With Zero Adverse Events

In this episode of "The Ultimate Human," Gary Brecka interviews Brigham Buhler about peptides, regenerative medicine, and the FDA's approach to these therapies. They discuss the potential of peptides and stem cells to improve healthspan and lifespan, emphasizing their safety and efficacy compared to traditional drugs. Buhler shares his efforts to engage with the FDA, providing data and testimonies to counter misinformation from pharmaceutical companies. Both express optimism about the future of regenerative medicine, highlighting the importance of proactive, personalized healthcare and the role of technology like AI in early disease detection and treatment. They advocate for informed consumer choice and the need to challenge dogma in healthcare, promoting a holistic approach that combines lifestyle changes with innovative therapies.